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Abstract
Background: Guidelines in the United Kingdom recommend that medication titration for attention deficit hyperactivity disorder
(ADHD) should be completed within 4-6 weeks and include regular reviews. However, most clinicians think that weekly clinic
contact is infeasible, and audits have shown that this timeline is rarely achieved. Thus, a more effective monitoring and review
system is needed; remote monitoring technology (RMT) may be one way to improve current practice. However, little is known
about whether patients with ADHD, their families, and clinicians would be interested in using RMT.
Objective: To explore patients’, parents’, and health care professionals’ views and attitudes toward using digital technology
for remote monitoring during titration for ADHD.
Methods: This was a qualitative study, and data were collected through 11 focus groups with adults and young people with
ADHD, parents of children with ADHD, and health care professionals (N=59).
Results: All participant groups were positive about using RMT in the treatment of ADHD, but they were also aware of barriers
to its use, especially around access to technology and integrating RMT into clinical care. They identified that RMT had the most
potential for use in the ongoing management and support of ADHD, rather than during the distinct titration period. Participants
identified features of RMT that could improve the quality of consultations and support greater self-management.
Conclusions: RMT has the potential to augment support and care for ADHD, but it needs to go beyond the titration period and
offer more to patients and families than monitoring through outcome measures. Developing and evaluating an mHealth app that
incorporates the key features identified by end users is required.
(JMIR mHealth uHealth 2016;4(1):e31)   doi:10.2196/mhealth.5009
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Introduction
Attention deficit hyperactivity disorder (ADHD) is a
neurodevelopmental syndrome characterized by 3 core
behaviors—inattention, hyperactivity, and impulsivity—and
affects approximately 5% of school-aged children [1]. Left
unmanaged, ADHD can result in impairments in multiple
domains, including academic performance, productivity, and
social adjustment, and can lead to an increased risk of conduct
and personality disorders or substance misuse [2]. Medication
is the most common treatment, with psychosocial interventions,
such as behavior training and parent training, being the main
alternatives [3]. Using digital technologies for eMental Health
(ie, the use of information and communication technologies
(ICT) to support and improve mental health, including the use
of online resources, social media, and mobile phone apps [4])
and mHealth (ie, mobile health [5]), has the potential to
transform the delivery of mental health care by connecting
patients, services, and health data in new ways [6]. Certain
features of digital technologies target specific deficiencies for
people with ADHD, such as automated reminders and task
scheduling to support organizational skills and immediate access
to avoid delay and waiting. They also offer the potential to
increase access to resource-intensive, and therefore scarce,
psychosocial interventions.
Developments of eMental Health for ADHD include digital and
Web-based psychometric tools [7]; behavioral interventions
[8]; cognitive and biofeedback training packages (some with
game-like features) [3,9]; and computerized cognitive
assessments [10]. While there is some evidence emerging about
these approaches, they remain largely experimental, and have
limited alignment to clinical practice [3,9]. For example, the
delivery of synchronous and asynchronous behavioral
interventions for ADHD with patients and parents has been
found to be acceptable, feasible, and effective [8]. Similarly, in
child and adolescent mental health services (CAMHS), recent
research has shown that eMeasures (ie, outcome measures
delivered electronically) are perceived positively by patients
and clinicians, and tend to have significantly higher completion
rates than do the standard approaches [7,11].
Internet availability and mobile devices are now within the reach
of most of the population, enabling new systems of health
monitoring to be considered without the previous problem of
excluding large sections of the population. In the United
Kingdom, 85% of all adults have household access to the
Internet, and this rises to 94% among 16-24 year olds;
furthermore, mobile Internet appears to have the fastest growing
audience (an increase of 11% from 27.2 million unique users
in March 2103 to 30.2 million by March 2014) [12]. By March
2015, 66% of all adults owned a mobile phone; among younger
age groups, there was nigh-universal ownership (87% for 25-34
years; 90% for 16-24 years) [13]. The mobile phone apps for
ADHD currently available through commercial app stores are
primarily tools for self-testing and information and management
strategies, task and scheduling aids, and brain training games
(according to a review of the Google Play and iTunes stores
performed in August 2015). While most apps target patients
and provide information and non-clinical advice, a small number
target clinicians to provide support for treatment decisions.
However, most apps have been developed outside of clinical
environments and few are supported by an evidence base [14].
Neither is it clear whether potential end-users have been
involved in the design and development of these tools. Given
these limitations in this and other health areas, serious concerns
have been raised about the safety, usability, and effectiveness
of unregulated health apps [15].
In the United Kingdom, an identified unmet need in ADHD
treatment is the delay in reaching the optimum dose for patients
commencing medication (personal communication, unpublished
audit, Hall, 2015). During initial medication titration, the
National Institute for Health and Care Excellence (NICE)
ADHD Guideline [1] recommends that progress be reviewed
regularly, such as by weekly telephone contact and at each dose
change, and that the entire process should occur over 4-6 weeks
[1]. However, weekly contact during titration is not viewed as
feasible by most clinicians in the UK National Health Service
(NHS) because of time and resource constraints (personal
communication (unpublished audit), Hall, 2015). Evidence from
the landmark Multimodal Treatment Study of Children with
ADHD in the United States [16] highlighted the importance of
high quality medication management in ADHD, including
carefully monitoring individual dose titration with regular
follow-up, in facilitating better outcomes for patients. Therefore,
a more effective system is needed to ensure that patients are
monitored closely but without increasing the strain on clinic
resources.
Remote monitoring technology (RMT) is a means of collecting
physiological or health-related data from individuals passively
or by their active input on an electronic device, such as a mobile
phone, and relaying these data over an internet or phone
connection to a remote server. Given the ubiquity of mobile
device use and Internet availability in the population, the
conditions for using RMT as an adjunct to traditional models
of service delivery appear better than ever. Using RMT offers
a potential solution to delays in titration currently experienced
in the NHS. However, little is known about whether patients
and health care professionals in the NHS context would support
the introduction of RMT to aid treatment monitoring for ADHD.
Moreover, there is a need to ensure the quality of any RMT
products and that patient and families’needs remain at the center
of any technology development and implementation [17].
Therefore, the aim of this study was to explore patients’,
parents’, and health care professionals’ views regarding the use
of RMT during medication titration for ADHD.
Methods
Design and Context
We conducted an exploratory cross-sectional focus group study
with patients, parents, and health professionals. Focus groups
were chosen as the preferred method of data collection for this
study because they enable an exploration of experiences and
views and facilitate discussion between participants on a topic
of shared interest [18]. The setting was 4 NHS mental health
provider areas in the East Midlands region of England, the
United Kingdom. An industrial partner [19] developed an initial
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prototype RMT system, which was used as a vehicle for
exploring participants’ views of this technology.
The prototype RMT enabled automated text messages to be sent
to patients who were invited to complete Web-based versions
of routine outcome measures (ROMs) to monitor symptoms
and side effects. The system comprised a clinician dashboard
where patient details were entered and the specific ROMs
required for each individual patient were selected. The
dashboard indicated when patients had completed their measures
and showed red flags for any issues of concern. To use the RMT
patients required a mobile phone to receive text messages and
activate the links to the Web-based versions of the ROM. Once
completed, the data were relayed back to the system server and
the clinician dashboard updated. The primary aim of the
prototype was to enable the clinic to receive information about
responses to and side effects of medication during the titration
period in addition to that obtained from face-to-face
appointments. Screenshots of the prototype are displayed in
Figures 1-3.
Figure 1. Screenshot of the prototype RMT: Text message received by patient.
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Figure 2. Screenshot of prototype RMT: Example ROM.
Figure 3. Screenshot of prototype RMT : Clinician dashboard.
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User Involvement in Study Design
Before undertaking the focus groups, a workshop was held to
elicit feedback on the prototype RMT system from potential
end-users. It was attended by a young person with ADHD and
his parent, 2 adults with ADHD, 1 psychiatrist, 1 psychologist,
and 1 medical technology researcher. This workshop identified
key factors to explore in more detail in the focus groups. The
experience of the workshop suggested that demonstrating the
prototype system during the focus groups would risk diverting
attention away from the primary research purpose. This was
primarily because the “on-boarding” process for the prototype
RMT was lengthy—individual patient details needed to be
entered into the clinician dashboard and patients needed to both
receive and reply to SMS text messages. In the short time we
had available in the scheduled focus groups, we determined that
this process would dominate the session and limit the time
needed for exploring participants’ views and acceptability of
the general concept of RMT. Therefore, we decided not to use
the prototype RMT in the focus groups, but instead created
printed materials from the system to aid in discussion (see
Figures 1-3).
Participants
The study sample comprised 8 young people with ADHD (YP),
11 adults with ADHD (adults), 9 parents of children with ADHD
(parents), and 31 health care professionals (HCP) working with
people with ADHD (see Table 1). YP, adults, and parents were
recruited through 2 routes: NHS ADHD clinics (CAMHS and
community pediatrics) or community ADHD support groups.
Inclusion criteria were a self-reported diagnosis of ADHD or
having a child with a self-reported diagnosis of ADHD. This
was checked by asking participants to confirm where they had
received the diagnosis (90% had received it in NHS clinics and
10% in private health care facilities). HCPs were recruited by
the local investigators at each NHS provider organization. The
criterion for inclusion was employment in a service treating
people with ADHD. A purposive sample of HCPs was sought
to reflect the range of staff involved in medication management
in clinical settings and implementation of any new systems.
Procedure
Eleven separate focus groups took place in areas with variable
relative deprivation including inner cities, post-industrial towns,
and semi-rural districts. They were held in locations convenient
to the participants (either NHS clinic or support group premises)
and took place between June and September 2014. Each group
was limited to a single participant type (see Table 1) [18] and
we aimed to hold at least 2 focus groups for each participant
type. We also made sure that each different mental health care
provider was represented by at least 1 HCP focus group to
enable an exploration of any differences in practice or attitudes
between the different provider organizations [18]. The YP
groups lasted for 45 and 50 minutes, while the groups with
adults, parents, and HCPs lasted 75-90 minutes.
The study received ethical approval from the UK National
Research Ethics Service Committee South Central - Berkshire
B (ref 13/SC/0641). Information about the study was sent to all
potential participants before the scheduled focus group date. At
the beginning of each session, the study was explained to
participants and any questions were answered. All adult
participants gave their written informed consent to take part.
Parents of the YP aged under 16 gave their written informed
consent for their children to take part, while the YP gave their
verbal assent. YP, adults, and parents were all given a £20
shopping voucher as a reward for their participation. HCPs all
took part during their usual working times, so no remuneration
was given to them.
Each focus group was facilitated by 2 members of the research
team. One member brought domain (insider) knowledge about
ADHD (ZY), while the other brought methodological (outsider)
knowledge about focus groups (LS or MC). The facilitators
sought to remain “background figures” [20] in the groups,
guiding the process, rather than leading it. Moreover, the insider
(domain) and outsider (methodological) perspectives were
combined to ensure the discussions remained focused on the
core topic while ensuring that researchers could still seek
clarification on assumed knowledge and implied meanings
between those with common experiences.
The discussions were guided by a topic schedule covering 4
key areas: using technology for health; medication titration
experience/practice; remote monitoring for effects and side
effects; and aspirations for using technology to manage ADHD
(see Appendix 1). Drawing on best practice advice for focus
groups [20], and especially for young people [21], we included
different activity-oriented questions in each group (see Table
2). These were designed to enrich the data collected, make it
easier to talk about sensitive topics (for example, medication
taking), and, importantly for our participants, reduce lapses in
attention [22]. Some of these activities were designed to ensure
that participants could express their views individually, and
thereby avoid inadvertent acquiescence bias to the researchers
or censoring by the other participants. Although 2 of the focus
groups had only 2 participants, the discussions were similar to
those in the larger groups in that they were highly interactive
and yielded equally rich data. Participants also completed a
short questionnaire on their demographic characteristics and
current technology use.
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Table 1. Number of participants in each focus group by study area
TotalParentsYoung peopleAdultsHealth care professionalsSite
13--49aSite 1
277677Site 2
1122-7Site 3
8---8Site 4
59981131Total
a Two focus groups were held with health care professionals at Site 1: 1 with 3 participants and 1 with 6 participants.
Table 2. Overview of the activity-oriented questions included in the focus groups
HCPsParentsAdultsYPActivity
✓✓Warm-up “rapid-fire” quiz
✓✓✓✓Data visualizations
✓✓✓Ideas on sticky notes
✓✓Rating personal experience
✓Personas and scenarios
✓✓✓✓Prototype screenshots
Data Analysis
All focus groups were audio recorded and transcribed. Adopting
an applied approach [23], thematic analysis [24] and charting
[25] were used to search for data patterns within and across the
different participant groups. An initial coding frame was
developed by 2 researchers (LS and AV), one of whom had not
been involved with data collection. This included independent
open coding of 4 transcripts each and joint discussion to agree
on a comprehensive coding frame. Through constant comparison
[26], all data were coded into the coding frame, which was
iterated when required and reapplied to the earlier transcripts.
The initial coding of the 4 transcripts (representing
approximately 35% of the dataset) was cross-checked for
reliability; this yielded 93% agreement (Ƈ=0.922, P<.001). Once
all of the data were organized into the refined coding frame,
members of the wider research team (LS, AV, CF, and MC)
engaged in detailed discussions, which led to the identification
of overarching, interpretative themes. These themes aimed to
capture the essence and strength of the participants’experiences
and views; by assigning individual codes to these themes, we
were able to maintain a close fit between the data and the more
abstract, interpretative themes. Theme-level matrixes [25] were
created to compare the nature and distribution of the data across
the participant groups.
Questionnaire data were entered into a database and analyzed
in SPSS 21 (IBM) by 1 team member (CF).
Results
Overview
Table 3 summarizes the demographic characteristics of the 59
participants. Both the patient and parent samples were
predominantly white British, and were mainly male, and female,
respectively. In all groups, there was a wide spread of ages,
apart from YP, who were all aged 12 or 13 years. The HCP
sample included 9 medical staff and 15 non-medical clinical
staff, of which 11 were prescribers, 5 were in non-clinical health
care roles, and 2 were IT managers.
Using digital technology was a frequent activity in all
participants’ lives. The vast majority of HCPs (27/31, 87%),
adults (10/11, 91%), and parents (7/8, 88%) used mobile phones
on a daily basis, whereas YP were more likely to use game
consoles (5/8, 63%) and tablet computers (5/8, 63%) on a daily
basis. Participants mostly used these devices to access the
Internet (54/59, 92%), while a majority also used them for apps
(39/59, 66%) and some adults, YP, and parents regularly used
them for playing games (15/28, 54%).
The qualitative analysis resulted in 5 key themes (see Table 4),
2 of which related to treatment and support for ADHD (ie,
complexity of medication decision making and access to
diagnosis, treatment, and support), while the other 3 related to
the role of RMT (potential of RMT to support people living
with ADHD, barriers and limitations to technology, and
imagining the ideal app). These themes are described and
expanded on below, and are supported by key quotations from
the participants. Although all 4 participant groups provided data
to support all 5 themes, we highlight any discrepancies in
emphasis across participant groups in the theme description.
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Table 3. Participant demographic information
Employment status (em-
ployed)
Ethnicity (white British)Age range (years)Gender (fe-
male)
TotalParticipant Group
312518-642231Health care professional
71018-54711Adult
0712-1318Young person
5825-5479Parent
Table 4. Overview of the analytic interpretative themes and contributing data codes
Contributing data codesSubthemesAnalytic interpretative themes
Personal expectations of medicationsComplexity of medication decision making
Medication—decision making
Medication effects
Confidence in prescribing
Communication with education professionals
Questionnaires
Communication with patients
Medication—experience of titrationAccess to diagnosis, treatment, and support
Experience of diagnosis (of ADHD)
Communication with health care professionals
Range of current use of websitesSymptom tracking to improve the quality of
clinic appointments
Potential of RMT to support living with ADHD
Range of current use of other technologySupporting greater self-management
Anticipated impact—self management
Anticipated impact—health care consultation
Acceptability and receptiveness (positive)
Tracking
Medication—experience
Barriers and limitations (negative)Access to technologyBarriers and limitations to using RMT
Perceived challenges of incorporating RMT
into clinical care
Content in ideal appOrganization aidImagining an ideal app
Coach/supporter/
motivator
Reliable, trustworthy and tailored information
Monitoring and tracking side effects and
symptoms
Complexity of Medication Decision Making
Across the sample, experiences of the titration period were
mixed. Some participants were content with the speed of the
titration and their level of contact with the clinic, while others
believed it to be a lengthy period to attain an acceptable level
of medication effect (up to 18 months). Very few participants
reported that titration had been achieved within the 6-week
period recommended by the NICE ADHD Guideline, and most
participants reported monthly or less face-to-face contact with
the clinic during titration. While few adults were satisfied with
this amount of contact, most of the parents were. In the adult
and parent groups, a visual scale was used for participants to
indicate their satisfaction with the titration process (see Figure
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4). This composite visualization (re-created to include all
participants’ responses and pseudonyms) shows a broad
variation in satisfaction.
HCPs generally reported that while titration may not always
meet NICE guideline timescales, their practice was as good as
could be delivered within current facilities and resources—more
frequent contact was prevented by limited clinic capacity or
high caseloads. Weekly monitoring and dose changes were
difficult to achieve as prescribers gathered information from a
number of sources (such as school reports) to guide their
decisions.
You need information from the young person, the
parent/carer, and ideally from the teacher, because
sometimes the young person doesn’t realize that the
medication is beneficial but the parent does. [HCP,
Site 1]
Despite being optimistic about the effects of the medication
when first prescribed, many participants described difficulties
in deciding whether to start or continue with it. Adults and
parents wanted to achieve an acceptable balance of positive
effects and side effects.
It’s a balancing act of getting enough done…You need
to say when it is “good enough”. Not getting
everything done but weighing up the health issues
and side effects. [Adult, Site 1]
Because of these experiences, many participants chose when to
take (or give their child) medication. HCPs were aware of this
and had differing degrees of acceptance of this. Whereas some
supported the patient or parent taking control, others were
concerned about inconsistent medication taking.
The use of clinical rating scales (or ROMs) to support titration
was not consistent across the study sites; where they were used,
it was always as an adjunct to the detailed, qualitative
information gathered in conversation and written school reports.
You can get a better understanding through a
telephone call and you can unpick things more in a
conversation, for example, a child is sleeping more
than they used to but not as much as the parent would
like. [HCP, Site 2]
HCPs across all groups raised concerns about the validity and
reliability of ROMs, such as whether they are sensitive enough
to detect subtle effects. ROMs were also believed to become
less informative with repetitive use, open to manipulation, and
difficult to interpret when responses differed between
respondents (eg, parents, teachers).
Figure 4. Visualization of adult and parent satisfaction with the titration period. (Note: this is a representation of data and all names are pseudonyms).
Access to Diagnosis, Treatment, and Support
Despite the primary focus of this study being the use of RMT
during the titration period, the focus group discussions were
dominated by issues relating to access to diagnosis, treatment,
and support, especially for adults and parents. Participants
recalled the “frustrating” and “lengthy process” of getting a
diagnosis and that it often took something “drastic,” such as a
“breakdown”, “meltdown,” or a number of job losses, before
they were taken seriously. Adults specifically mentioned that
“getting someone to listen” or “having a doctor that believed
in [ADHD]” was key to their diagnosis, as opposed to being
“fobbed off,” “labeled lazy and idle,” or “[labeled as] naughty.”
The difficulties in access to diagnosis, treatment, and support
appeared to eclipse the experience of medication titration. By
the point of diagnosis and commencing medication, adults and
parents were so relieved to have access to treatment and support
that the time needed to reach the optimum dose of medication
was of less importance to them. This experience was supported
by comments from some HCPs, as well.
My cases are usually diagnosed in adolescence so
they have been waiting for their ADHD to be treated
for years, so a few more weeks [for titration] is not
a big deal. The important thing is that the process
has started. [HCP, Site 1]
Although there were some examples of positive experiences,
most parents and adults highlighted substantial organizational
and logistical issues regarding access to treatment; in particular,
they cited long waiting times, brief appointments, lengthy
intervals between appointments, inconsistent doctors,
unpredictable communication, and frequent cancellations.
Both parent and adult groups expressed a need for further
support. One adult specifically reported “I’m getting down, I’m
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not coping. I feel like I’ve been left on my own a bit really”
[Adult, Site 2]. In addition to support for side effects and
symptoms, participants expressed the need for “reassurance”
[Parent, Site 2], “someone there if you have a problem”
[Parent, Site 3], and “information from someone who “gets it”
more than professionals do” [Adult, Site 1].
Potential of RMT to Support Living With ADHD
As described above, there was widespread use of
Internet-enabled mobile devices, computers, and game consoles
across the sample, but their use in relation to ADHD was fairly
limited. With the exception of YP, all other groups reported
using websites for ADHD information. Parents, adults, and
HCPs were cautious about Web information; they wanted to
access (or recommend) only trusted or reputable websites. A
small number of participants used existing generic mobile phone
functions to support daily activities (calendar, reminders, lists,
and timers). HCPs described how they sometimes recommended
general relaxation and meditation apps, rather than apps
specifically designed for people with ADHD.
However, across the whole sample, there were highly positive
attitudes toward the potential for RMT to play a greater role in
the management of ADHD. Many participants reported that it
could improve communication with the clinic; furthermore,
participants across all groups saw its potential to (a) improve
the quality of the clinic appointments/consultations and (b)
support greater patient self-management.
Symptom Tracking to Improve the Quality of Clinic
Appointments
Parents, adults, and HCPs thought that using RMT would save
time in clinic appointments by enabling a quicker review of the
patient’s recent history and thereby swifter identification of
what matters most to the patient/parent.
This way you can look back over the previous 4 weeks
or 3 months and focus on questions such as—“you
scored sleep a 2 here, what was happening at the time
that made it so unsettled?” It should help parents to
be more productive in giving the information we need.
[HCP, Site 3]
Participants also thought that data collected contemporaneously,
rather than retrospectively, would not be biased by patient recall
and selective memory.
Supporting Greater Self-Management
Participants saw the potential for RMT to provide the ability to
easily monitor symptoms, chart them over time, and identify
any patterns or unusual behaviors. This would increase people’s
knowledge, self-awareness, and understanding of and confidence
in dealing with their condition. All of the groups also saw the
potential for RMT to offer personalized feedback in response
to patient-entered data. This could be used for reassurance, to
avoid unnecessary contact with the clinic, and for motivating
feedback to reinforce positive behaviors.
It could be a bar with red at the bottom and green at
the top and a little person and after each check-up,
it moves up or down to show how well you are doing
so it gives you the opportunity to realize and change
it. [YP, Site 3]
Sometimes I think I’m doing well for a few weeks,
then I look back and realize I wasn’t. Something to
help me accurately monitor that. That in itself would
be an aid to the medication… so you can look back
and see what you’ve done well and what things you
need to concentrate on doing better. [Adult, Site 2]
While participants broadly welcomed the concept of RMT,
specific feedback on the prototype pointed to some important
limitations in this approach. For YP, adults, and parents, the
prototype did not allow them to retain and use their own (or the
child’s) data, and therefore was unable to realize their vision of
its supporting greater self-management described above. For
HCPs, the primary issue was that the prototype was perceived
as onerous to use and difficult to incorporate into current
workflows (for a further description of this, see the “Barriers
and limitations to using RMT” section below). They emphasized
the need for an RMT that saves clinician time rather than adds
to it by requiring additional management outside of the current
electronic patient record.
Barriers and Limitations to Using RMT
The barriers and limitations to using RMT were highlighted in
all focus groups, although HCPs foresaw more barriers than did
parents, YP, or adults.
Access to Technology
Although most participants used Internet-enabled mobile
devices, they thought that other people might have had
difficulties in physically accessing the technology or having the
necessary skills to use it. This included access to mobile devices,
especially ones that would support any new app/software (all
groups); access to phones when at school (YP); access to
wireless Internet in different locations (YP and HCPs); and
capability for interoperability with NHS hardware (HCPs).
Perceived Challenges of Incorporating RMT Into
Clinical Care
RMT was seen as a positive addition to the clinical process only
if it “adds to what’s there already...not if it’s used as an excuse
to see people less” [Adult, Site 2]. HCPs were keen on receiving
digital information that coincided with patients’ appointments,
but noted that “if you start getting notifications about patients
from another area clinic it will take up too much time” [HCP,
Site 3], and stressed that all of their time spent dealing with
digital data be accounted for and appropriately factored into the
provider contract. Confidentiality of personal data and privacy
was discussed by several groups, as was the need to consider
information governance problems and to protect young people
from any harms arising from digital tools.
Some HCPs and adults were concerned with providing
information digitally to clinics, as it may not be responded to
promptly, whereas a phone call would be more likely to elicit
a response. Others felt this could be useful information, as long
as it was understood that the information might not be seen
immediately and that patients should be directed to alternative
sources of support when needed.
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Imagining an Ideal App
Participants across all groups were keen to imagine and discuss
the functions of their ideal mobile phone app for ADHD. There
were similarities across groups regarding the proposed primary
functions as well as the preference for personalization, regarding
both users’ ability to control settings and to receive tailored
responses. YP also wanted any tool intended for daily use to be
“challenging… and funny” [YP, Site 3]. Taken together, the
feedback on the prototype RMT and their views on an ideal app
points toward a preference for RMT to be controlled by patients,
rather than clinics. Four primary functions were identified:
organizational aid; a digital coach or mentor; reliable,
trustworthy, and tailored information; and symptom or side
effect monitoring.
Organization Aid
Organization aids were frequently mentioned in all groups, apart
from YP. For example, 1 HCP thought that a reminder system
would be useful:
The difficulties I come across, [are that] young people
are on medication and they tend to run out at the end
of the month and their behavior will go sky high, and
it will take them a week to get all the medication back
into their system. I think it would be really useful if
somewhere in the app, say when they’re...near the
end [they receive a message saying] “You need to
put in a request for repeat prescription.” [HCP, Site
3]
Parents supported this idea, especially as YP begin taking more
responsibility for managing their ADHD. Adults wanted support
with day-to-day tasks: “something that helps you keep on task
and achieve goals...incorporating pre-set plans and lists of
tasks” [Adult, Site 2]. Another discussed the utility of a timing
app:
To figure out how long it takes you to do certain daily
tasks eg, showering. The app could then tell you what
time you would need to get up to get everything done
[Adult, Site 1].
A Coach/Supporter/Motivator
Adults, YP, and HCPs identified potential features that could
act as a virtual “coach” [Adult, Site 1], such as providing
supportive statements and motivation:
[It] could have some information based on how long
the process should take with messages such as “you
may not be seeing any improvements yet, but stick
with it”... or you could have messages to parents,
such as “Derek might be struggling this week” [HCP,
Site 3]
Reliable, Trustworthy, and Tailored Information
All participant groups suggested that the app should provide
reliable and precise information, based on both personal
experiences and professional knowledge. Information about
medications was in particular sought by adults, while parents
and HCPs wanted links to reputable sites and resources,
including existing apps and support groups; YP wanted
information about ADHD books. HCPs suggested that an app
could give proactive advice about behavior, sleep, and diet.
They also felt advice should be targeted with frequently asked
questions and specific, tailored responses, such as “I’m feeling
dizzy—[the] advice would be to go to see your GP” [HCP, Site
4].
Monitoring and Tracking Side Effects and Symptoms
There was strong support across all groups to track information
visually, such as using a graph to illustrate changes in symptoms,
side effects, and behavior over time. YP suggested that
monitoring mood swings and side effects might be useful. HCPs
wanted the ability to monitor medication compliance and side
effects, as well as tracking behaviors such as eating, sleeping,
and drug and alcohol use during titration. The usefulness of
being able to link this information with life events was also
identified:
Graphs would be useful for example for... patients
who stop taking meds but parents and teachers say
they have improved. It might help to have the parent
and teacher graphs to see. [HPC, Site 4]
Adults wanted the mode of recording information to be tailored
to individual preferences, for example, using smiley faces to
record mood, using the voice recorder, and linking with other
apps such as work calendars. HCPs felt it would be useful if
school staff could provide feedback through the app. Parents
were happy for YP to enter their own data when they were
mature enough, but also wanted to provide feedback and report
how they themselves are doing.
Discussion
Principal Results
The participants in this study reflect current trends in technology
use [12,13], particularly with regard to their high use of mobile
technologies (eg, Internet-enabled mobile phones and tablets).
While few currently used these devices in relation to ADHD
(ie, patients or HCPs), we found widespread support for
augmenting ADHD treatment and support with RMT, eHealth,
and mHealth apps. However, 2 important findings from this
study indicate that the purpose and functions of the initial
prototype did not align with participants’ priorities.
First, while our initial interest in conducting this study was to
explore how RMT could improve titration management, and
even though our findings support audit work suggesting that
the NICE guidelines are not currently met in NHS services
(personal communication (unpublished audit) by Hall, 2015),
few participants identified this as an area of high unmet need.
The exploratory nature of the study enabled new ideas to emerge
that moved us beyond titration. Through participants’ detailed
accounts, we identified 3 clear phases of living with ADHD:
initial assessment and diagnosis; starting treatment (including
medication titration); and ongoing support and management.
The group discussions with adults, YP, and parents were
dominated by their experience of the first phase—namely, trying
to access services and getting a formal diagnosis, as described
in our second theme (access to diagnosis, treatment, and
support). This adds to previous evidence of this being an area
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of high unmet need [2]. Once diagnosed, the experience of relief
and optimism was similar to that reported in other studies [27],
as was their recognition of the long-term implications of ADHD
[28], the need for ongoing support in living with ADHD, and
the limitations of medication [27].
Second, participants identified that RMT’s greatest potential
was in improving ongoing support and management of ADHD.
The use of RMT to improve ADHD by continuing the health
care interventions between appointments has previously been
recognized [14]. In this study, 2 key advantages were
highlighted—tracking to improve the quality of clinic
appointments and support for greater self-management.
While there have been calls for increased use of ROMs and
clinical measures to enhance clinical practice [29], there are
several barriers to widespread adoption [30]. Some of these
barriers were identified in this study—specifically, increased
burden on clinics, questions about the clinical utility of the data,
and the need for information from a range of sources,
particularly regarding medication-decision making. It has been
argued that technology may make ROMs more useful by
providing data in a form that is timely and accessible by patients,
families, and clinicians [31]. Our findings support those of Hall
et al. [11], who found that regular monitoring using electronic
ROMs allowed for tracking progress and facilitating
communication and engagement. As identified by participants
in this study, using mobile phone/tablet apps for completing
ROMs has the potential to save time for both clinicians and
patients [32] and may provide more accurate data than
paper-based questionnaires [33]; however, some academics
caution against simple translation of paper-based questionnaires
to digital formats without further validation [34].
Participants in this study demonstrated a preference for an RMT
system that supports greater self-management—namely, one
that is patient-owned and controlled, such that patients/parents
can choose when and how to use it and specifically when to
share the information with their clinician. The widespread
adoption of mobile phones and tablet computers in the
population makes them advantageous over other digital devices
as they are very portable and frequently in the owner’s
possession throughout the day [15]. These devices afford the
opportunity for the use of low-cost apps that can support clinical
management at any time of day or in any location [35] through
provision of trusted information, real-time monitoring and
symptom tracking, prompts and medication reminders,
personalized behavioral support, and communication with health
care services. However, the value of apps to the health care
system will only be fully realized once the data generated from
them is shared between patients, carers, and clinicians to
improve their efficiency and quality of care.
Although there are some ADHD-specific mobile phone apps
available, we are not aware of any evaluations or evidence of
their clinical benefit. Research has shown that using generic
mobile phone features such as calendars, task lists, and notes,
with the support of a human online coach, can be effective in
managing ADHD symptoms [36]. Extending this approach with
a bespoke ADHD tool that incorporates the 4 key features
identified in this study (organizational aid, virtual coach, reliable
and tailored information, and monitoring and feedback) is
proposed as the next step for research. This tool also needs to
include positive reinforcement such as rewards for completion
and game-like features (a process called “gamification”) to
enhance user engagement [14], which could meet YP
requirements for any tools to be fun and challenging. In addition
to rating symptoms and treatment progress monitoring, an RMT
system could complement therapy, psychoeducation, support,
and advice [37].
Our study has demonstrated the vital importance of developing
systems in collaboration with the end users. The next stage of
research and development for RMT for ADHD will be to adopt
well-established user-centered approaches with rapid, iterative
cycles of requirements elicitation, design, testing, and redesign
[38]. The findings of this study provide a strong foundation to
commence this stage, and will also help with testing the efficacy
of the RMT during its development; this is a crucial part of
beginning to build evidence for the clinical effectiveness of any
new RMT.
Greater patient activation, including self-management and
self-monitoring, is a goal for many long-term conditions, not
only ADHD. The primary findings from this study—that RMT
has a place throughout the patient’s journey (not only targeted
at a single stage) and the overwhelming preference for
patient-controlled, rather than clinic-controlled systems—may
also apply across other neurodevelopmental and mental health
disorders. Our use of the HCP sample in this study adds support
to this point, as they came from CAMHS and pediatric services
where they would treat a range of different conditions. However,
it will be important to test these assumptions with other
populations; in particular, the detailed user requirements for an
ADHD-focused RMT may not transfer directly to other
conditions and populations.
Strengths and Limitations
By engaging with a range of participants, we have explored the
commonalities and differences across the key stakeholder
groups. We found universal support for technology innovation
across these groups and identified their preferences for how this
could be implemented. Diversity with respect to gender, age,
and ethnicity across our sample was limited, meaning that we
may have missed some important perspectives. However, it
should be noted that the ethnic profile of our sample reflects
previous findings of studies of access to care, where white
children were twice as likely as access services than were
children from other ethnic groups [39].
By using a defined prototype as a discussion vehicle for RMT
within a defined clinical condition, we may have narrowed the
scope of the discussion and the ideas of what would be useful
or possible. For example, while access to diagnosis was
identified as the most significant unmet need, participants’
aspirations for technological support focused on treatment and
support. However, many of the ideas proposed diverged from
the specific approach taken with the prototype, suggesting that
participants had clear ideas for when and how technology would
be helpful to them.
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Conclusions
The findings from this study strongly suggest that YP, parents,
and adults with ADHD are looking for a more personalized,
responsive approach to ADHD treatment and support in the
long term. Patients and their families want more targeted
information at a time they need it most, to have control over
interventions including medication, to have facilities to record
and monitor personal and sensitive information about
themselves, and to have support in developing personal
strategies that fit with their lives. This study of patients’,
parents’, and HCPs’ views of using RMT for ADHD leads us
to the conclusion that a technology-based personalized approach
for living with ADHD, driven by user requirements, is required.
However, implementing RMT requires a key change in the
philosophy of health care from routinized clinic-centered care
to personalized patient-centered care.
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